A comparison between upfront high-dose tirofiban versus provisional use in the real-world of non-selected STEMI patients undergoing primary PCI
A.A.C.M. Heestermans, R.S. Hermanides, A.T.M. Gosselink, M.J. de Boer, J.C.A. Hoorntje, H. Suryapranata, J.P. Ottervanger, J-H.E. Dambrink, E. Kolkman, J.M. ten Berg, F. Zijlstra, A.W.J. van ’t HofVolume:
18
Language:
english
Pages:
6
DOI:
10.1007/s12471-010-0840-z
Date:
November, 2010
File:
PDF, 239 KB
english, 2010